NEW

Study Confirms Surfacide UV-C Kills SARS-CoV-2

A recent peer-reviewed study in the Journal of Clinical Anesthesia* found the Surfacide Helios® System UV-C technology is nearly 95% effective in preventing SARS CoV-2 in patient environments. This is the first clinical study that evaluates the use of UV-C in...

AORN Recommends Nasal Decolonization with PVP-I

The Association of periOperative Registered Nurses (AORN) has announced its annual updated recommendations on the "Guideline for Preoperative Skin Antisepsis," to assist health care professionals in navigating risk-based decisions for developing preoperative...

New AAAHC Quality Roadmap Probes Data, Highlights Surveyor Insights

On June 16, AAAHC released its 2021 Quality Roadmap, a comprehensive analysis of data from more than 1,120 accreditation surveys conducted in 2020.

RSIP Vision Reveals New Module

RSIP Vision has announced its new surgical workflow analysis technology, which can intelligently identify each separate stage of a surgical procedure and label them accordingly throughout the duration of the procedure.

Court Dismisses Lawsuits Against Patient Warming System

3M has announced that a federal court dismissed all of the federal lawsuits against the 3M Bair Hugger system. The legal victory comes after six years of defending the company’s patient warming system.

The decision dismisses more than 5,000 lawsuits filed by plaintiffs’ attorneys, who claimed that the warming system was responsible for infections suffered by patients during surgery. Those lawsuits were consolidated in a multidistrict litigation in federal court in Minnesota.

The federal decision in favor of 3M comes six months after the Minnesota Court of Appeals upheld a Minnesota state court order dismissing 61 similar cases filed by lawyers on behalf of Minnesota plaintiffs.

“There is no legitimate scientific support for the plaintiffs’ theory. We are pleased that the court has dismissed all of the cases in the multidistrict litigation,” said Dr. Todd Fruchterman, general manager, 3M Medical Solutions Business. “Most importantly, we want physicians and patients to understand that the practice of patient warming is supported by leading health care institutions, professional societies and the U.S. Food and Drug Administration. Our industry-leading 3M Bair Hugger system has been proven to be a safe, effective and efficient method of delivering patient warming therapy.”

In its order, the federal court granted 3M’s request to exclude the plaintiffs’ general causation experts, leaving the plaintiffs with no scientific support for their claims. The court previously had agreed to allow the plaintiffs’ experts to testify in court. After those experts testified in the first Bair Hugger system trial in 2018 and after the publication of a new study on surgical site infections, 3M asked the court to revisit its earlier decision.

3M argued that the new evidence further proved that the plaintiffs’ experts lacked scientific support for their claims. On July 31, 2019, the court granted 3M’s motion.

The company says the plaintiffs’ infection theory was invented by 3M competitor Augustine Temperature Management and its founder Scott Augustine.

This court decision does not dismiss two similar cases filed in state courts in Missouri and Texas.

In August 2017, the U.S. Food and Drug Administration sent a letter to health care providers stating that it continues to recommend the use of patient warming devices, including forced-air warming devices, for surgical procedures when clinically warranted.

Previous

Next

Submit a Comment

Your email address will not be published. Required fields are marked *

X